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Introduction
The decrease of perinatal mortality in diabetic
pregnancies is considered a significant achievement
in modern obstetrics [2, 6, 14]. This favourable
development is partially due to intensive monitor-
ing of the fetus during pregnancy and labor. In
spite of the improved fetal outcome, intrauterine
fetal deaths still occur during diabetic pregnancies.
Although the mechanisms of fetal death in diabe-
tes are poorly understood, reported signs of
asphyxia before and during labor [3, 6, 9] suggest
that uteroplacental insufficiency may be one of
the reasons. Nonstress testing (NST) and contrac-
tion stress testing (CST) have proved effective in
fetal surveillance in many groups of high risk
pregnancy [3, 5, 13]. In diabetic pregnancies,
however, documented cases of fetal distress and
intrauterine deaths have been reported to occur
even within one day after negative NST [20] and
CST [4]. Therefore, detection of fetuses at risk
of fetal distress is still an important problem in
managing diabetic pregnancies. Decreasing variabil-
ity of FHR has been claimed to be prognostic for
poor fetal outcome in other high risk pregnancies
[8, 12, 15, 22, 18]. In the present study, the short
term variability of antepartal FHR was quantitated
in order to assess its clinical significance as a




born in 1946 in Finland.
She studied medicine in
Helsinki University and
graduated in 1973. She
specialised in Obstetrics
and Gynecology in 1980
and is working in the
Departments of Obstetrics
and Gynecology, Helsinki
University Central Hos- ?
pita I. Field of interest:
Perinatal medicine.
··«?· i* · v ·
!AV:.;.fc..fe..
2 Patients and methods
2.1 Normal pregnancies
The reference material consisted of 65 strictly
normal pregnancies with good fetal outcome [12].
The first lower percentile of antepartal differential
indices (DI) in this reference material was used as
the normal limit of DI.
2.2 Diabetic pregnancies
The group studied consisted of 120 insulin-
dependent diabetic mothers, who were treated
at the Departments of Obstetrics and Gynecology
of Helsinki University Central Hospital. Diabetes
in pregnancy was classified according to WHITE
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[19] as modified by PEDERSEN [17]. Patients
who needed insulin only during pregnancy were
classified as A/B (15 cases). Four mothers in
class F had proliferative retinopathy and five had
nephropathy. Twelve mothers had pre-eclampsia,
six had a mild hypertensive disease, and three
had cholestasis of pregnancy. All were singleton
pregnancies.
2.3 Fetal distress
Antepartal NSTs were used as a primary clinical
tool in fetal surveillance. All fetuses were moni-
tored by cardiotocography (CTG) during labor or
at least 24 hours before an elective cesarean sec-
tion. Fetal distress was recorded when a perinatal
death occurred or at least two of the following
signs were present: Apgar score less than seven at
one or five minutes, more than two late decelera-
tions in FHR during labor or before cesarean
section, total variability (visually evaluated) of
FHR less than five beats per minute for at least
five minutes under the same circumstances and
acidosis in fetal scalp blood (pH < 7.20 and/or
base excess >13.0mEq/l by SALING method).
Classification of patients with modes of delivery
and signs of fetal distress is presented in Tab. I.
• r
2.4 Measurement of the short term variability of
FHR
The DIs were measured by a previously described
on-line method which utilizes abdominal fetal
electrocardiography (aFECG) as a triggering signal
[10]. The analysis of FHR variability was regarded
as a failure when less than 30 per cent of fetal
interval differences were accepted in the analysis.
The FHR analyses were performed at one to four
week intervals either during visits to the clinic or
during the mothers' stay in the hospital. The time
from testing DI to the delivery varied from less
than one up to 139 days (mean 31, SP 26).
2.5 Assessment of the test
The value of antepartal DI as a predictor of intra-
partal fetal condition was assessed from those
pregnancies, where FHR analyses were performed
during the last week before delivery (93 cases).






Fig. 1. Distribution of the 308 DIs measured from 5 minute samples of abdominal fetal electrocardiograms of 110
diabetic pregnancies. The first lower percentile limit of DI in normal pregnancies with good fetal outcome has been
drawn for reference. Thirty fetuses had 37 pathological DIs.
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Tab. I. Distribution of pregnancies, modes of delivery and signs of fetal distress in different classes of diabetes mellitus.














































































five categories: Failures of the analysis, correct
positives (fetuses with one or more pathological
DIs and fetal distress), correct negatives (fetuses
with normal DIs and without fetal distress), false
positives (fetuses with one or more pathological
DIs without subsequent fetal distress) and false
negatives (fetuses with normal DIs with sub-
sequent fetal distress). Four statistical descriptors
were used to assess the clinical value of the test
(DI): Sensitivity was defined by the percentage of
fetuses with a correct positive result in the group
with fetal distress. Predictive value was the correct
positives as a percentage of all positive results.
Specificity was the percentage of fetuses with
correct negative results in the group without
fetal distress. Relative risk was the ratio of the
percentage of positives that were true positives
to the percentage of negatives that were false
negatives [1]. Statistical significance of difference
between the two percentages in the calculation of
relative risk was assessed by the chi squared test
with VAXES' correction.
3 Results
No intrauterine deaths occurred. Two newborn
infants died (one with multiple malformations and
the other with asphyxia and prematurity). The
perinatal mortality was thus 1.7%. Five infants
were born with major congenital malformations
(4 %). One mother (White class D complicated by
severe pre-eclampsia) suffered from a cerebral
hemorrhage after cesarean section and never
regained consciousness.
FHR analysis never succeeded during ten preg-
nancies and was successful at least once in 110
pregnancies, with a total of 308 measured DIs.
The scattergram of antepartal DIs in diabetic
pregnancies is presented in Fig. 1. Fetal distress
developed in 28 out of 110 pregnancies with
successful FHR analysis. Modes of delivery and the
signs of fetal distress in different classes are shown
in Tab. I. Thirty fetuses had 37 pathological DIs
out of 308 measured.
Two antepartal DIs, one ten days and the other
two days before cesarean section of a 29 weeks old
fetus predicted correctly its neonatal death at. 13
hours' age. Three antepartal DIs at two weeks'
intervals and the latest two weeks before cesarean
section of another fetus at its 36th week failed to
predict its death at two hours' age. The baby had
multiple anomalies.
Assessment of the last week's DI as a predictor of
fetal distress in labor is presented in Tab. II.
Tab. II. Antepartal differential index (DI) as a gredictor of fetal distress in diabetic pregnancies (* = p < 0.001)
Number of Failures of Differential Fetal distress
fetuses analyses index yes no
Sensitivity Predictive Specificity Relative







67 71 92 8.5*
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Antepartal DI detected 12 of the 17 fetuses with
fetal distress (sensitivity 67%). Twelve of the 18
fetuses with at least one pathological DI developed
fetal distress (predictive value 71%). Sixty-seven
of the 73 fetuses without fetal distress had normal
DIs (specificity 92%). The risk of fetal distress
after a pathological DI was 8.5 times that after
a normal DI (relative risk), which is highly signifi-
cant.
4 Discussion
The present study suggests that antepartal DI is a
rather reliable predictor of fetal outcome during
diabetic pregnancies.
Fetal distress developed in 26% of the cases,
which is in agreement with previous reports [7].
The most frequent signs of fetal distress were fixed
baseline of FHR (32%) and late decelerations
(27%), which indicate the role of uteroplacental
insufficiency in developing fetal distress of diabe-
tic pregnancies. Fixed baseline of FHR probably
indicates a decreased function of autonomous
nervous system. Thus this study also supports
some previous reports on high frequencies of
abnormal FHR patterns during diabetic preg-
nancies and labors [2, 9, 14, 20]. A new and some-
what astonishing finding of the present study was,
that signs of fetal distress were equally frequent in
different WHITE'S classes of diabetes.
We have stated previously that false positives are
not a problem of antepartal DI in other risk
groups. The present study shows that in diabetic
pregnancies the number of false positives is com-
parable with those in other risk groups [12, 22].
We have observed that low DIs during diabetic
pregnancies are associated with maternal hyper-
glycemia [11]. Whether episodes of low DIs during
diabetic pregnancies are associated with lowered
intervillous placental blood flow, as we presume,
remains to be investigated. We have observed
previously that the failure rate of aFECG is the
main problem of antepartal analysis of FHR
variability [12, 22]. In the present study the
failure rate is of the same magnitude as in the
previously studied risk groups. We do not regard
the failure rate as a major problem since visual
evaluation of cardiograms is continuously improving
as FHR analyses are performed by the obstetric
staff. The person analyzing can provide an imme-
diate answer as to whether- the analyzed strip is
normal or abnormal.
Summary
The clinical significance of quantified short term variabil-
ity of antepartal fetal heart rate (FHR) in prediction
of fetal distress in labor was assessed in 120 insulin-
dependent diabetic pregnancies. FHR was recorded by
abdominal fetal electrocardiography (aFECG), from
which the differential indices (DI) describing the short
term variability of FHR were analyzed by a micro-
processor-based on-line method. The analysis was success-
ful in 308 of 350 trials (87%). In ten pregnancies, no
acceptable a FECG was obtained. Fetal distress developed
in 28 of the 110 pregnancies with successful FHR analy-
sis. There were no intrauterine deaths in this series, but
two newborn infants died (perinatal mortality 1.7%).
Ninety-three pregnancies with 'FHR analyses within
one week of delivery were included in the assessment
of the test. DI predicted 12 of the 17 cases of fetal
distress (sensitivity 67%). Twelve of the 18 cases with a
pathological DI developed fetal distress (predictive value
71 %). DIs were normal in 67 of the 73 pregnancies with-
out fetal distress (specificity 92%). Risk of fetal distress
after a pathological DI was 8.5 times that after normal
DIs (relative risk), which is highly significant.
Keywords: Antepartal, diabetes mellitus, electrocardiography, fetal heart, heart rate variability.
Zusammenfassung
Kurzfristige Änderungen der fetalen Herzfrequenz bei
Schwangerschaften mit insulinpflichtigem Diabetes
Wir ermittelten die klinische Bedeutung von quantitativ
erfaßten kurzfristigen Änderungen der fetalen Herz-
frequenz (FHR) für die Prognose eines fetalen Distress-
Syndroms unter der Geburt in 120 Schwangerschaften
mit insulinpflichtigem Diabetes. Die FHR wurde mitteis
der abdominal abgeleiteten fetalen Elektrocardiographie
(aFECG) aufgezeichnet und daraus die Differentialindices
(DI), die die kurzfristigen Änderungen der FHR beschrei-
ben, über ein Mikroprozessor-System mit der On-Line-
Methode bestimmt. In 308 von 350 Aufzeichnungen
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kamen wir zu verwertbaren Daten. Bei 10 Schwangeren
konnte kein brauchbares aFECG abgeleitet werden. Ein
fetales Distress-Syndrom entwickelte sich in 28 der
insgesamt 110 Fälle mit erfolgreicher FHR-Analyse. In
dieser Untersuchungsgruppe gab es keinen Fall von
intrauterinem Fruchttod, aber 2 Neugeborene starben
(perinatale Sterblichkeit: 1,7%). Bei der Bewertung
unserer Methode wurden 93 Schwangerschaften, in denen
innerhalb einer Woche vor der Entbindung FHR-Analysen
erstellt worden waren, berücksichtigt. Der DI sagte in 12
von 17 Fällen, in denen ein fetales Distress-Syndrom
auftrat, dieses richtig voraus (Empfindlichkeit: 67%).
Ein pathologischer DI wurde in 18 Fällen erhoben; davon
entwickelten dann 12 ein fetales Distress-Syndrom
(Prädiktabilität 71%). Die DI's waren bei 67 der 73
Schwangerschaften ohne fetales Distress-Syndrom als
normal eingestuft worden (Spezifität: 92%). Wenn ein
pathologischer DI vorlag, war das Risiko eines fetalen
Distress-Syndroms 8,5 mal höher als nach normalen DI's;
dieser Unterschied ist hochsignifikant.
Schlüsselwörter: Diabetes mellitus in der Schwangerschaft, Elektrocardiographie, fetale Herzfrequenz, fetale Herz-
frequenzänderungen.
Resume
Instabilite ä court terme du rythme cardiaque foetal au
cours de la grossesse des diabetiques insulino-dependantes
La signification clinique de l'instabüite ä court terme
quantifiee du rythme cardiaque foetal (RCF) pendant la
grossesse pour la prediction de la souffrance foetale en
cours de travail a ete etudiee chez 120 grossesses de
diabetiques insulino-dependantes. Le RCF a ete enregistre
par electrocardiographie foetale par voie abdominale
(ECGFa), ä partir duquel Tindice differentiel (ID) qui
represente Tinstabilite ä court terme du RCF a ete analyse
au moyen d'un micro-ordinateur fonde sur une methode
lineaire. L'analyse a ete couronnee de succes dans 308
enregistrements sur 350 tentatives (87 %). ON n'a pas pu
obtenir d'ECGFa satisfaisant pour 10 grossesses. Une
souffrance foetale est apparue chez 28 des 110 grossesses
ayant eu une analyse du RCF couronnoe de succes. II n'y
a pas eu de morts foetales in utero dans cette serie, mais 2
nouveaux-nes sont decedes (soit une mortalite perinatale
de 1,7%). 93 grossesses ayant eu une analyse du RCF
au cours de la semaine precedant Taccouchement ont
ete incluses dans revaluation du test. L'lD a permis
la prediction de 12 des 17 souffrances foetales (sensibiiite
de 67%). 12 des 18 cas avec un ID pathologique ont
presente une souffrance foetale (valeur predictive: 71 %).
L'lD a ete normal dans 67 des 73 grossesses sans souffr-
ance foetale (specificite: 92%). Le risque de souffrance
foetale apres un ID pathologique est 8,5 fois plus eleve
qu'apres un ID normal (risque relatif) ce qui est hautement
significatif.
Mots-cles: Antepartum, coeur foetal, diabete sucre, electrocardiographie, instabilite du rythme cardiaque.
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